通过增加MCM7表达,E2F8促进了肌肉侵入性膀癌的恶性表型
Li-Yun Liu1,2, Liang Tian3, Ling-Huan Gao4
1Department of Pathology, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Biochemistry and cell biology = Biochimie et biologie cellulaire
|November 27, 2024
概括
E2F转录因子8 (E2F8) 在膀癌中升高,促进瘤生长和对西斯普拉丁的耐药性. 抑制E2F8抑制了癌症的进展和增强了亡,这表明E2F8是治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞循环规则 细胞循环规则
背景情况:
- E2F转录因子8 (E2F8) 是一个关键的细胞循环调节剂.
- E2F8的失调与各种癌症有关.
- 对于E2F8在膀癌进展和治疗耐药性方面的作用尚未完全阐明.
研究的目的:
- 研究E2F8在膀癌中的表达和功能.
- 确定E2F8与临床阶段和患者结果之间的关联.
- 探索E2F8作为膀癌治疗点的潜力.
主要方法:
- 在膀癌组织和细胞系中分析E2F8表达.
- 在体外和体内进行E2F8敲击实验.
- 细胞增殖,迁移,入侵和细胞灭绝的测试.
- 对蛋白质表达的西部斑点分析 (Cyclin D1,MCM7).
- 染色体免疫沉 (ChIP) 试验以评估E2F8与MCM7促进体的结合.
主要成果:
- 在膀癌组织中,E2F8的表达上调,与更高的临床阶段相关.
- E2F8 knockdown 抑制膀癌细胞的增殖,诱导G1阶段的停止,并减少迁移和入侵.
- 低调 E2F8 增强了膀癌细胞中西斯普拉丁诱导的亡.
- E2F8直接与MCM7促进体结合并激活它,而MCM7的过度表达会挽救E2F8淘汰的效应.
- 在体内,E2F8 knockdown抑制了膀癌的进展.
结论:
- 在膀癌中,E2F8是致癌的,促进了扩散,入侵和对西斯普拉丁的抗性.
- E2F8通过调节MCM7.8来至少部分地发挥其功能.
- E2F8代表了膀癌治疗的潜在治疗标.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:23Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K